May 25, 2017
In spite of growing R&D expenditures, truly new technologies are not coming from the largest multi-national diagnostic technology companies. They are coming from entrepreneurs, who are creating an appetite for M&A. The demand for our portfolio is already here.
We will improve health and create wealth, by investing in technologies to change healthcare from probabilistic and population-based, to precise, predictive and personal.